Terms: = Endocrine gland cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
136 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. [Tolerability and Outcome of Neoadjuvant GS Therapy for Resectable Pancreatic cancer].
Yamashita M; Shimizu J; Sato Y; Noma T; Hagihara K; Yanagimoto Y; Suzuki Y; Ikenaga M; Kawase T; Imamura H; Akagi K; Iwasawa S; Tomita N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1411-1413. PubMed ID: 38303291
[TBL] [Abstract] [Full Text] [Related]
3. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced Pancreatic cancer: A Multicenter Retrospective Study.
Lee J; Park JS; Jeong S; Lee DH; Lim JH; Cho SG; Kwon CI; Hyun JJ; Choe JW; Cho JH; Jang SI
Turk J Gastroenterol; 2023 Dec; 34(12):1249-1256. PubMed ID: 37860834
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Kitano Y; Inoue Y; Takeda T; Oba A; Ono Y; Sato T; Ito H; Ozaka M; Sasaki T; Sasahira N; Baba H; Takahashi Y
Ann Surg Oncol; 2023 Aug; 30(8):5093-5102. PubMed ID: 37140750
[TBL] [Abstract] [Full Text] [Related]
9. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
[TBL] [Abstract] [Full Text] [Related]
10. The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis.
Meng YF; Fan ZY; Yang J; Li YZ; Liu SJ; Gao CH; Gao X; Pang CY; Zhan HX
Front Endocrinol (Lausanne); 2023; 14():1137911. PubMed ID: 37033225
[TBL] [Abstract] [Full Text] [Related]
11. Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis.
Huang Z; Wang J; Zhang R; He A; Luo S; Wu R; Xiong J; Li M; Jin T; Li E; Wu L; Liao W
Cancer Med; 2023 Apr; 12(8):9926-9936. PubMed ID: 36850060
[TBL] [Abstract] [Full Text] [Related]
12. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports.
Ko YL; Kumar V; Lippert J; Diaz-Cano S; Skordilis K; Kimpel O; Kircher S; Asia M; Elhassan YS; Altieri B; Ronchi CL
BMC Endocr Disord; 2023 Jan; 23(1):4. PubMed ID: 36604647
[TBL] [Abstract] [Full Text] [Related]
13. Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth.
Liu H; Zhang H; Liu X; Guo W; Liu Q; Chen L; Pang J; Liu X; Li R; Tong WM; Wu H; Dai M; Liang Z
Cancer Lett; 2023 Feb; 555():216040. PubMed ID: 36565920
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-suppressive miR-29c binds to MAPK1 inhibiting the ERK/MAPK pathway in pancreatic cancer.
Si H; Zhang N; Shi C; Luo Z; Hou S
Clin Transl Oncol; 2023 Mar; 25(3):803-816. PubMed ID: 36510038
[TBL] [Abstract] [Full Text] [Related]
15. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
[TBL] [Abstract] [Full Text] [Related]
16. Cribriform - morular thyroid carcinoma: a rare entity.
Michnová U; Traboulsi E; Peková B; Ryška A
Cesk Patol; 2022; 58(2):107-110. PubMed ID: 35882545
[TBL] [Abstract] [Full Text] [Related]
17. Do antihypertensive drugs really have antitumor effects? Baseline differences in hypertensive and non-hypertensive patients with advanced pancreatic cancer.
Iede K; Yamada T; Ueda M; Tsuda Y; Nakashima S; Ohta K; Tanida T; Matsuyama J; Ikenaga M; Tominaga S
Medicine (Baltimore); 2022 Jul; 101(29):e29532. PubMed ID: 35866833
[TBL] [Abstract] [Full Text] [Related]
18. prognosis following an extended duration of adjuvant gemcitabine plus S-1 chemotherapy in patients with pancreatic ductal adenocarcinoma: Analysis using inverse probability of treatment weighting.
Kondo N; Uemura K; Sumiyoshi T; Okada K; Seo S; Otsuka H; Kawano R; Murakami Y; Takahashi S
J Hepatobiliary Pancreat Sci; 2022 Aug; 29(8):911-921. PubMed ID: 35435318
[TBL] [Abstract] [Full Text] [Related]
19. Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups.
Yan C; He X; Chen Z; Wang Y
Front Endocrinol (Lausanne); 2022; 13():807431. PubMed ID: 35250865
[TBL] [Abstract] [Full Text] [Related]
20. Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving multi-agent chemotherapy: A single center, retrospective cohort study.
Uemura S; Iwashita T; Ichikawa H; Iwasa Y; Mita N; Shiraki M; Shimizu M
Pancreatology; 2022 Mar; 22(2):304-310. PubMed ID: 35153128
[TBL] [Abstract] [Full Text] [Related]
[Next]